Please enable JavaScript to continue using this application.

Compare $ICCC vs $SERA | Chartloom

Compare

$ICCC vs $SERA

ImmuCell Corp · Sera Prognostics Inc

ICCC

ImmuCell Corp

SERA

Sera Prognostics Inc

Compare $ICCC vs $SERA

Comparing ImmuCell Corp and Sera Prognostics Inc

ICCCImmuCell Corp

SERASera Prognostics Inc

ICCCImmuCell Corp

Market cap

$89M

P/E (TTM)

114.37x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

8.5%

YTD performance

65.5%

52W performance

48.7%

FCF yield

4.8%

SERASera Prognostics Inc

Market cap

$80M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

89.94x

Rev growth (TTM)

-35.2%

YTD performance

-32.0%

52W performance

-35.2%

FCF yield

-35.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ICCC

SERA

Detailed metrics comparison

ICCC

ImmuCell Corp

SERA

Sera Prognostics Inc

Market Cap

ICCC$89M

SERA$80M

Enterprise Value

ICCC$88M

SERA$75M

Price

ICCC$9.80

SERA$2.04

P/E Ratio

ICCC114.37x

SERAN/A

P/S Ratio

ICCC2.89x

SERA1,141.23x

EV/Sales

ICCC2.87x

SERA1,078.41x

EV/EBITDA

ICCC14.10x

SERA0.00x

P/B Ratio

ICCC2.82x

SERA1.39x

P/FCF Ratio

ICCC21.04x

SERAN/A

EV/FCF

ICCC20.91x

SERA-2.68x

PEG Ratio

ICCCN/A

SERAN/A

Forward P/E (NTM)

ICCCN/A

SERAN/A

Forward P/S (NTM)

ICCCN/A

SERA89.94x

Revenue (TTM)

ICCC$31M

SERA$70K

Revenue Growth (YoY)

ICCC8.5%

SERA-35.2%

Forward Rev Growth

ICCC0.0%

SERA791.9%

Gross Margin (TTM)

ICCC40.3%

SERA-150.0%

Operating Margin (TTM)

ICCC3.9%

SERA0.0%

EBITDA Margin (TTM)

ICCC20.4%

SERA-50200.0%

Net Margin (TTM)

ICCC2.6%

SERA-47475.7%

FCF Margin (TTM)

ICCC13.7%

SERA-40262.9%

Net Income (TTM)

ICCC$787K

SERA$-33M

FCF (TTM)

ICCC$4M

SERA$-28M

EPS (TTM)

ICCC$0.09

SERA-$0.66

ROE (TTM)

ICCC2.7%

SERA-4671.0%

ROA (TTM)

ICCC1.8%

SERA-3406.0%

ROIC (TTM)

ICCC2.1%

SERA-4671.0%

Cash

ICCC$9M

SERA$4M

Debt

ICCC$8M

SERA$0

Net Cash/Debt

ICCC$557K

SERA$4M

Current Ratio (TTM)

ICCC4.75x

SERA1.98x

Quick Ratio (TTM)

ICCC2.65x

SERA1.91x

Debt/Equity (TTM)

ICCC0.26x

SERA0.00x

Debt/Assets (TTM)

ICCC0.0%

SERA0.0%

Interest Coverage (TTM)

ICCCN/A

SERAN/A

Net Debt/EBITDA (TTM)

ICCC0.00x

SERA0.00x

Beta

ICCC0.60

SERA1.09

52W Performance

ICCC48.7%

SERA-35.2%

YTD Performance

ICCC65.5%

SERA-32.0%

% from 52W High

ICCC-19.0%

SERA-48.4%

% from 52W Low

ICCC116.8%

SERA30.8%

Asset Turnover (TTM)

ICCC0.69x

SERA0.00x

FCF Yield (TTM)

ICCC4.8%

SERA-35.3%

Earnings Yield (TTM)

ICCC0.9%

SERA-41.6%

Dividend Yield (TTM)

ICCCN/A

SERAN/A

Rule of 40

ICCC22.2

SERA-40,298.0

EV/GP/RG

ICCCN/A

SERAN/A

Ticker research

View ICCC research View SERA research

Metric	ICCC ImmuCell Corp	SERA Sera Prognostics Inc
Market & Valuation
Market Cap	$89M	$80M
Enterprise Value	$88M	$75M
Price	$9.80	$2.04
P/E Ratio	114.37x	N/A
P/S Ratio	2.89x	1,141.23x
EV/Sales	2.87x	1,078.41x
EV/EBITDA	14.10x	0.00x
P/B Ratio	2.82x	1.39x
P/FCF Ratio	21.04x	N/A
EV/FCF	20.91x	-2.68x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	89.94x
Revenue & Growth
Revenue (TTM)	$31M	$70K
Revenue Growth (YoY)	8.5%	-35.2%
Forward Rev Growth	0.0%	791.9%
Profitability
Gross Margin (TTM)	40.3%	-150.0%
Operating Margin (TTM)	3.9%	0.0%
EBITDA Margin (TTM)	20.4%	-50200.0%
Net Margin (TTM)	2.6%	-47475.7%
FCF Margin (TTM)	13.7%	-40262.9%
Net Income (TTM)	$787K	$-33M
FCF (TTM)	$4M	$-28M
EPS (TTM)	$0.09	-$0.66
ROE (TTM)	2.7%	-4671.0%
ROA (TTM)	1.8%	-3406.0%
ROIC (TTM)	2.1%	-4671.0%
Financial Health
Cash	$9M	$4M
Debt	$8M	$0
Net Cash/Debt	$557K	$4M
Current Ratio (TTM)	4.75x	1.98x
Quick Ratio (TTM)	2.65x	1.91x
Debt/Equity (TTM)	0.26x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	1.09
52W Performance	48.7%	-35.2%
YTD Performance	65.5%	-32.0%
% from 52W High	-19.0%	-48.4%
% from 52W Low	116.8%	30.8%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	0.00x
FCF Yield (TTM)	4.8%	-35.3%
Earnings Yield (TTM)	0.9%	-41.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	22.2	-40,298.0
EV/GP/RG	N/A	N/A
Ticker research	View ICCC research	View SERA research

Valuation

P/E Ratio

ICCC

114.37x

P/S Ratio

ICCC

2.89x

SERA

1,141.23x

EV/FCF

SERA

-2.68x

ICCC

20.91x

Growth & revenue

Revenue Growth TTM

ICCC

8.5%

SERA

-35.2%

Forward Revenue Growth

SERA

791.9%

ICCC

0.0%

Profitability & performance

Gross Margin

ICCC

40.3%

SERA

-150.0%

ROE

ICCC

2.7%

SERA

-4671.0%

FCF Yield %

ICCC

4.8%

SERA

-35.3%

52-Week Performance

ICCC

48.7%

SERA

-35.2%

Detailed metrics comparison

ICCC

ImmuCell Corp

SERA

Sera Prognostics Inc

Market Cap

ICCC$89M

SERA$80M

Enterprise Value

ICCC$88M

SERA$75M

Price

ICCC$9.80

SERA$2.04

P/E Ratio

ICCC114.37x

SERAN/A

P/S Ratio

ICCC2.89x

SERA1,141.23x

EV/Sales

ICCC2.87x

SERA1,078.41x

EV/EBITDA

ICCC14.10x

SERA0.00x

P/B Ratio

ICCC2.82x

SERA1.39x

P/FCF Ratio

ICCC21.04x

SERAN/A

EV/FCF

ICCC20.91x

SERA-2.68x

PEG Ratio

ICCCN/A

SERAN/A

Forward P/E (NTM)

ICCCN/A

SERAN/A

Forward P/S (NTM)

ICCCN/A

SERA89.94x

Revenue (TTM)

ICCC$31M

SERA$70K

Revenue Growth (YoY)

ICCC8.5%

SERA-35.2%

Forward Rev Growth

ICCC0.0%

SERA791.9%

Gross Margin (TTM)

ICCC40.3%

SERA-150.0%

Operating Margin (TTM)

ICCC3.9%

SERA0.0%

EBITDA Margin (TTM)

ICCC20.4%

SERA-50200.0%

Net Margin (TTM)

ICCC2.6%

SERA-47475.7%

FCF Margin (TTM)

ICCC13.7%

SERA-40262.9%

Net Income (TTM)

ICCC$787K

SERA$-33M

FCF (TTM)

ICCC$4M

SERA$-28M

EPS (TTM)

ICCC$0.09

SERA-$0.66

ROE (TTM)

ICCC2.7%

SERA-4671.0%

ROA (TTM)

ICCC1.8%

SERA-3406.0%

ROIC (TTM)

ICCC2.1%

SERA-4671.0%

Cash

ICCC$9M

SERA$4M

Debt

ICCC$8M

SERA$0

Net Cash/Debt

ICCC$557K

SERA$4M

Current Ratio (TTM)

ICCC4.75x

SERA1.98x

Quick Ratio (TTM)

ICCC2.65x

SERA1.91x

Debt/Equity (TTM)

ICCC0.26x

SERA0.00x

Debt/Assets (TTM)

ICCC0.0%

SERA0.0%

Interest Coverage (TTM)

ICCCN/A

SERAN/A

Net Debt/EBITDA (TTM)

ICCC0.00x

SERA0.00x

Beta

ICCC0.60

SERA1.09

52W Performance

ICCC48.7%

SERA-35.2%

YTD Performance

ICCC65.5%

SERA-32.0%

% from 52W High

ICCC-19.0%

SERA-48.4%

% from 52W Low

ICCC116.8%

SERA30.8%

Asset Turnover (TTM)

ICCC0.69x

SERA0.00x

FCF Yield (TTM)

ICCC4.8%

SERA-35.3%

Earnings Yield (TTM)

ICCC0.9%

SERA-41.6%

Dividend Yield (TTM)

ICCCN/A

SERAN/A

Rule of 40

ICCC22.2

SERA-40,298.0

EV/GP/RG

ICCCN/A

SERAN/A

Ticker research

View ICCC research View SERA research

Metric	ICCC ImmuCell Corp	SERA Sera Prognostics Inc
Market & Valuation
Market Cap	$89M	$80M
Enterprise Value	$88M	$75M
Price	$9.80	$2.04
P/E Ratio	114.37x	N/A
P/S Ratio	2.89x	1,141.23x
EV/Sales	2.87x	1,078.41x
EV/EBITDA	14.10x	0.00x
P/B Ratio	2.82x	1.39x
P/FCF Ratio	21.04x	N/A
EV/FCF	20.91x	-2.68x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	89.94x
Revenue & Growth
Revenue (TTM)	$31M	$70K
Revenue Growth (YoY)	8.5%	-35.2%
Forward Rev Growth	0.0%	791.9%
Profitability
Gross Margin (TTM)	40.3%	-150.0%
Operating Margin (TTM)	3.9%	0.0%
EBITDA Margin (TTM)	20.4%	-50200.0%
Net Margin (TTM)	2.6%	-47475.7%
FCF Margin (TTM)	13.7%	-40262.9%
Net Income (TTM)	$787K	$-33M
FCF (TTM)	$4M	$-28M
EPS (TTM)	$0.09	-$0.66
ROE (TTM)	2.7%	-4671.0%
ROA (TTM)	1.8%	-3406.0%
ROIC (TTM)	2.1%	-4671.0%
Financial Health
Cash	$9M	$4M
Debt	$8M	$0
Net Cash/Debt	$557K	$4M
Current Ratio (TTM)	4.75x	1.98x
Quick Ratio (TTM)	2.65x	1.91x
Debt/Equity (TTM)	0.26x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	1.09
52W Performance	48.7%	-35.2%
YTD Performance	65.5%	-32.0%
% from 52W High	-19.0%	-48.4%
% from 52W Low	116.8%	30.8%
Efficiency & Yields
Asset Turnover (TTM)	0.69x	0.00x
FCF Yield (TTM)	4.8%	-35.3%
Earnings Yield (TTM)	0.9%	-41.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	22.2	-40,298.0
EV/GP/RG	N/A	N/A
Ticker research	View ICCC research	View SERA research